INVO Fertility, Inc. (IVF)
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
INVO Fertility, Inc.
NASDAQ:IVFHealthcare · Medical - Devices
-10.93%$1.91
AH$2.02+5.76%vs close
Mkt Cap$2.2M
Float1.14M
O/S1.15M
Vol
$ Vol
RVOL
Inst Own3.8%
SI0.6%
Earnings
Dilution
Pipeline3 lead-sponsored trials·0 active1 completed
Trials need funding. See this company's dilution risk and cash position.
Clinical Trials
Status
- Not applicableSuspended
Assessment of the INVOcell Intravaginal Culture System
INVOcell
Infertility
NCT04246268Enrollment180StartOct 2020est.Primary CompletionJul 2021est.CompletionMar 2022est. - Not applicableCompleted
Assessment of the INVOcell Culture Device When Used for up to Five-Day Incubation
INVOcell
Infertility
NCT04644380Enrollment31StartDec 2020Primary CompletionDec 2020CompletionDec 2020 - ObservationalUnknown status
3 Year Retrospective Analysis of IVF in Comparison With INVOcell
INVOcell IVC
Infertility
NCT05189405Enrollment450StartOct 2021Primary CompletionFeb 2022est.CompletionFeb 2022est.
| Drug / Therapy | Link | ||
|---|---|---|---|
| Not applicable | Suspended | INVOcell | NCT04246268 |
| Not applicable | Completed | INVOcell | NCT04644380 |
| Observational | Unknown status | INVOcell IVC | NCT05189405 |